score_bin	sensitive_predictive_implication	resistance_predictive_implication	prognostic_predictive_implication	feature_type	feature	alteration_type	alteration	tumor_f	total_coverage	exac_af	exac_common	clinvar	sensitive_score_bin	sensitive_therapy_name	sensitive_therapy_strategy	sensitive_therapy_type	sensitive_description	sensitive_citation	sensitive_url	resistance_score_bin	resistance_therapy_name	resistance_therapy_strategy	resistance_therapy_type	resistance_description	resistance_citation	resistance_url	prognostic_score_bin	favorable_prognosis	prognostic_description	prognostic_citation	prognostic_url	number_germline_mutations_in_gene	validation_total_coverage	validation_tumor_f	validation_detection_power	feature_display	preclinical_efficacy_observed	patient_id	tumor_sample_barcode	normal_sample_barcode
Investigate Actionability	Preclinical		Clinical evidence	Somatic Variant	JAK1	Nonsense	p.Q387*	0.1071	28.0	0.0	0.0		Investigate Actionability	PU-H71	HSP90 inhibition	Targeted therapy	MOHITO JAK1 V658F transplated mice were highly sensitive to growth inhibition by PU-H71.	Kucine N, Marubayashi S, Bhagwat N, et al. Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias. Blood. 2015;126(22):2479-83.	https://doi.org/10.1182/blood-2015-03-635821								Investigate Actionability	0.0	A study of target-specific sequencing data taken from 112 ALL patients showed an association between JAK1 or JAK2 mutation and decreased survival.	Feng J, Li Y, Jia Y, et al. Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia. J Hematol Oncol. 2017;10(1):61.	https://doi.org/10.1186/s13045-017-0431-1	0	0.0	0.0	0.0	JAK1 p.Q387* (Nonsense)		KIRP-2Z-A9JI	KIRP-2Z-A9JI-TP	KIRP-2Z-A9JI-NB
Biologically Relevant				Rearrangement	BRIP1	Fusion	MAP3K3--BRIP1			0.0	0.0																					0				MAP3K3--BRIP1 Fusion		KIRP-2Z-A9JI		
Biologically Relevant				Copy Number	BRIP1	Amplification				0.0	0.0																					0				BRIP1 Amplification		KIRP-2Z-A9JI	TCGA-2Z-A9JI-01	
Biologically Relevant				Microsatellite Stability	Supporting variants		JAK1 p.Q387* (Nonsense), PRDM2 p.703_704insP (Insertion), MSH3 p.AAA58del (Deletion), PMS2 p.V372fs (Frameshift)																									0				Supporting variants: JAK1 p.Q387* (Nonsense), PRDM2 p.703_704insP (Insertion), MSH3 p.AAA58del (Deletion), PMS2 p.V372fs (Frameshift)		KIRP-2Z-A9JI		
Biologically Relevant				Mutational Signature	COSMIC Signature 6	version 2	0.399																									0				COSMIC Signature (version 2) 6 (40%)		KIRP-2Z-A9JI		
Biologically Relevant				Mutational Signature	COSMIC Signature 16	version 2	0.325																									0				COSMIC Signature (version 2) 16 (32%)		KIRP-2Z-A9JI		
